EUVIMEDEUVIMED entdecken
Crossref

TRMT13 Facilitates SPAST Upregulation Through ceRNA Crosstalk and Modulates G3 ‐ YSD ‐Triggered Energy Metabolic Decline in Cardiomyocytes

Liangyong Liu, Hong Wu, Yan Wang, Zeyu Huang, Xiangqi Li, Qingyun Zhu

Clinical and Experimental Pharmacology and Physiology · 2026-05 · 53 (5)

DOI: 10.1111/1440-1681.70127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Pharmacology and Physiology, online erschienen am 12.05.2026. Verfasst von Liangyong Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Punan Hospital in Pudong New District, Shanghai, China. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Energy Metabolism, Up-Regulation, RNA, Competitive Endogenous. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Key Discipline Construction Project of Pudong Health Bureau of Shanghai, Shanghai Pudong New District Commission of Science and Technology and Economy, New Quality Clinical Specialties of High-end Medical Disciplinary Construction in Pudong New Area.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Viral infections are a major cause of cardiac metabolic dysfunction, leading to diseases like viral myocarditis and heart failure. In this study, we used G3‐YSD, a synthetic DNA mimic from the HIV‐1 genome, to model cytoplasmic viral DNA stress and aim to elucidate the mechanistic roles of TRMT13 and SPAST in cardiomyocyte metabolic impairment under conditions mimicking viral infection. Through functional assays such as ATP quantification and Seahorse XF metabolic stress tests on H9C2 and AC16 cells, we found that G3‐YSD treatment suppressed cardiomyocyte energy metabolism in a dose‐ and time‐dependent manner, with upregulation of TRMT13 and SPAST. Further analysis revealed a strong positive association between these two genes. Functional knockdown experiments showed that silencing TRMT13 or SPAST alleviated G3‐YSD‐induced energy metabolic impairment. Mechanistically, miR‐409‐3p was identified as a key intermediary directly targeting the 3′UTRs of TRMT13 and SPAST, with TRMT13 mRNA acting as a ceRNA to promote SPAST expression. In vivo validation using a G3‐YSD‐treated mouse model confirmed that knocking down TRMT13 or SPAST, or delivering miR‐409‐3p mimics, improved cardiac function and systemic metabolic activity, while SPAST overexpression negated these effects. Our study identifies a novel TRMT13–miR‐409‐3p–SPAST regulatory axis mediating cardiomyocyte energy metabolic decline in response to cytoplasmic viral DNA stress, revealing a nonmethyltransferase, nonimmune, ceRNA‐based mechanism of a newly characterised tRNA methyltransferase in viral infection‐induced cardiac metabolic dysfunction and proposing new molecular targets for therapeutic intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocytes, CardiacEnergy MetabolismUp-RegulationRNA, Competitive EndogenousAnimalsMiceCell LineMicroRNAsRatsHumans

Stichwörter der Autor:innen

G3‐YSDSPASTTRMT13cardiac metabolismceRNA networkenergy homeostasismiR‐409‐3pviral infection

Substanzen

RNA, Competitive EndogenousMicroRNAs

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, Punan Hospital in Pudong New District, Shanghai, China.
  • Department of Endocrinology and Metabolism, Gongli Hospital of Shanghai Pudong New Area, Shanghai, China.
  • Department of Intervention, Gongli Hospital of Shanghai Pudong New Area, Shanghai, China.

Förderung

  • Key Discipline Construction Project of Pudong Health Bureau of Shanghai
  • Shanghai Pudong New District Commission of Science and Technology and Economy
  • New Quality Clinical Specialties of High-end Medical Disciplinary Construction in Pudong New Area

Zitieren

APA

Liu, L., Wu, H., Wang, Y., Huang, Z., Li, X., & Zhu, Q. (2026). TRMT13 Facilitates SPAST Upregulation Through ceRNA Crosstalk and Modulates G3 ‐ YSD ‐Triggered Energy Metabolic Decline in Cardiomyocytes. Clinical and Experimental Pharmacology and Physiology, 53(5). https://doi.org/10.1111/1440-1681.70127

Vancouver

Liu L, Wu H, Wang Y, Huang Z, Li X, Zhu Q. TRMT13 Facilitates SPAST Upregulation Through ceRNA Crosstalk and Modulates G3 ‐ YSD ‐Triggered Energy Metabolic Decline in Cardiomyocytes. Clinical and Experimental Pharmacology and Physiology. 2026;53(5). doi:10.1111/1440-1681.70127

BibTeX
@article{Liu2026,
  author = {Liu, Liangyong and Wu, Hong and Wang, Yan and Huang, Zeyu and Li, Xiangqi and Zhu, Qingyun},
  title = {TRMT13 Facilitates SPAST Upregulation Through ceRNA Crosstalk and Modulates G3 ‐ YSD ‐Triggered Energy Metabolic Decline in Cardiomyocytes},
  journal = {Clinical and Experimental Pharmacology and Physiology},
  year = {2026},
  volume = {53},
  number = {5},
  doi = {10.1111/1440-1681.70127}
}
Kostenlos starten →